17β-Hydroxysteroid dehydrogenases: Physiological roles in health and disease

Trends in Endocrinology and Metabolism

Volumn 9, Issue 7, 1998, Pages 265-270

  Moghrabi, Nabil ^a   Andersson, Stefan ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE 17BETA DEHYDROGENASE;

ANDROGEN SYNTHESIS; BREAST CANCER; ENZYME ACTIVITY; ESTROGEN SYNTHESIS; GENE DELETION; HORMONAL CARCINOGENESIS; HUMAN; MALE PSEUDOHERMAPHRODITISM; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW;

EID: 0032171313     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(98)00066-6     Document Type: Review

References (50)

1. Adams EF, Coldham NG, James V Steroidal regulation of oestradiol-17β-dehydrogenase activity of the human breast cancer cell line MCF-7. J Endocrinol. 118:1988;149-154.
2. Akinola LA, Poutanen M, Vihko R Cloning of rat 17β-hydroxysteroid dehydrogenase type 2 and characterization of tissue distribution and catalytic activity of rat type 1 and type 2 enzymes. Endocrinology. 137:1996;1572-1579.
3. Akinola LA, Poutanen M, Vihko R, Vihko P Expression of 17β-hydroxysteroid dehydrogenase type 1 and type 2, P450 aromatase, and 20α-hydroxysteroid dehydrogenase enzymes in immature, mature, and pregnant rats. Endocrinology. 138:1997;2886-2892.
4. Andersson S, Geissler WM, Wu Let al. Molecular genetics and pathophysiology of 17β-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab. 81:1996;130-136.
5. Bernstein L, Ross RK Endogenous hormones and breast cancer risk. Epidemiol Rev. 15:1993;48-65.
6. + identifies two principal targets for the design of inhibitors. Structure. 4:1996;905-915.
7. Casey ML, MacDonald PC, Andersson S 17β-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium. J Clin Invest. 94:1994;2135-2141.
8. Chetrite G, Paris J, Botella J, Pasqualini JR Effect of nomegestrol acetate on estrone-sulfatase and 17β-hydroxysteroid dehydrogenase activities in human breast cancer cells. J Steroid Biochem Mol Biol. 58:1996;525-531.
9. Corbould AM, Judd SJ, Rodgers RJ Expression of types 1, 2, and 3 17β-hydroxysteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women. J Clin Endocrinol Metab. 83:1998;187-194.
10. Dumont M, Luu-The V, Dupont Eet al. Characterization, expression, and immunohistochemical localization of 3β-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase in human skin. J Invest Dermatol. 99:1992;415-421.
11. Durocher F, Morissette J, Labrie Yet al. Mapping of the HSD17β2 gene encoding type II 17β-hydroxysteroid dehydrogenase close to D16S422 on chromosome 16q24.1-q24.2. Genomics. 25:1995;724-726.
12. Elo JP, Akinola LA, Poutanen Met al. Characterization of 17β-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate. Int J Cancer. 66:1996;37-41.
13. Fournet-Dulguerov N, MacLusky NJ, Leranth CZet al. Immunohistochemical localization of aromatase cytochrome P-450 and estradiol dehydrogenase in the syncytiotrophoblast of the human placenta. J Clin Endocrinol Metab. 65:1987;757-764.
14. Geissler WM, Davis DL, Wu Let al. Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nat Genet. 7:1994;34-39.
15. Ghersevich SA, Poutanen MH, Rajaniemi HJ, Vihko RK Expression of 17β-hydroxysteroid dehydrogenase in the rat ovary during follicular development and luteinization induced with pregnant male serum gonadotrophin and human chorionic gonadotrophin. J Endocrinol. 140:1994;409-417.
16. Guillemette C, Hum DW, Belanger A Evidence for a role of glucuronosyltransferase in the regulation of androgen action in the human prostatic cancer cell line LNCaP. J Steroid Biochem Mol Biol. 57:1996;225-231.
17. Henseler T, Christophers E Psoriasis of early and late onset and characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 13:1985;450-456.
18. 3 regulates estrogen metabolism in cultured keratinocytes. Endocrinology. 138:1997;3711-3718.
19. James VHT, McNeill JM, Lai LCet al. Aromatase activity in normal breast and breast tumour tissue: in vivo and in vitro studies. Steroids. 50:1987;269-279.
20. Jarabak J, Adams JA, Williams-Ashman HG, Talalay P Purification of a 17β-hydroxysteroid dehydrogenase of human placenta and studies on its transhydrogenase function. J Biol Chem. 237:1962;345-357.
21. Jörnvall H, Persson B, Krook Met al. Short-chain dehydrogenases/reductases (SDR). Biochemistry. 34:1995;6003-6013.
22. Kirschner MA, Samojlik E, Drejka Met al. Androgen-estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrinol Metab. 70:1990;473-479.
23. Krotkiewski MP, Bjorntorp P, Sjostrom L, Smith U Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest. 72:1983;1150-1162.
24. Labrie Y, Durocher F, Lachance Yet al. The human type II 17β-hydroxysteroid dehydrogenase gene encodes two alternatively spliced mRNA species. DNA Cell Biol. 14:1995;849-861.
25. Labrie F, Luu-The V, Lin SXet al. The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology. Steroids. 62:1997;148-158.
26. Luu-The V, Labrie C, Zhao HFet al. Characterization of cDNAs for human estradiol 17β-dehydrogenase and assignment of the gene to chromosome 17: evidence for two mRNA species with distinct 5′-termini in human placenta. Mol Endocrinol. 3:1989;1301-1309.
27. Luu-The V, Labrie C, Simard Jet al. Structure of two in tandem human 17β-hydroxysteroid dehydrogenase genes. Mol Endocrinol. 4:1990;268-275.
28. Luu-The V, Sugimoto Y, Puy Let al. Characterization, expression and immunohistochemical localization of 5α-reductase in human skin. J Invest Dermatol. 102:1994;221-226.
29. Luu-The V, Zhang Y, Poirier D, Labrie F Characteristics of human types 1, 2, and 3 17β-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition. J Steroid Biochem Mol Biol. 55:1995;581-587.
30. Mäentausta O, Sormunen R, Isomaa Vet al. Immunohistochemical localization of 17β-hydroxysteroid dehydrogenase in the human endometrium during the menstrual cycle. Lab Invest. 65:1991;582-587.
31. Moghrabi N, Head JR, Andersson S Cell type-specific expression of 17β-hydroxysteroid dehydrogenase type 2 in human placenta and fetal liver. J Clin Endocrinol Metab. 82:1997;3872-3878.
32. Moghrabi N, Hughes IA, Dunaif A, Andersson S: 1998. Deleterious missense mutations and silent polymorphism in the human 17β-hydroxysteroid dehydrogenase 3 gene (HSD17B3). J Clin Endocrinol Metab (in press).
33. Mustonen MVJ, Poutanen MH, Isomaa VV, Vihko PT, Vihko RK Cloning of mouse 17β-hydroxysteroid dehydrogenase type 2, and analyzing expression of the mRNAs for types 1, 2, 3, 4 and 5 in mouse embryos and adult tissues. Biochem. J 325:1997;199-205.
34. Nokelainen P, Puranen T, Peltoketo Het al. Molecular cloning of mouse 17β-hydroxysteroid dehydrogenase type 1 and characterization of enzyme activity. Eur J Biochem. 236:1996;482-490.
35. Odlind V, Carlstrom K, Michaelsson Get al. Plasma androgenic activity in women with acne vulgaris and in healthy girls before, during and after puberty. Clin Endocrinol. 16:1982;243-249.
36. Okamoto M, Lee C, Oyasu R Autocrine effects of androgen on proliferation of an androgen responsive prostatic carcinoma cell line, LNCaP: role of interleukin-6. Endocrinology. 138:1997;5071-5074.
37. Peltoketo H, Isomaa V, Poutanen M, Vihko R Expression and regulation of 17β-hydroxysteroid dehydrogenase type 1. J Endocrinol. 150:1996;S21-S30.
38. Poutanen M, Isomaa V, Lehto V-P, Vihko R Immunological analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue. Int J Cancer. 50:1992;386-390.
39. Puranen T, Poutanen M, Ghosh Det al. Origin of substrate specificity of human and rat 17β-hydroxysteroid dehydrogenase type 1, using chimeric enzymes and site directed substitutions. Endocrinology. 138:1997;3532-3539.
40. Recchione C, Venturelli E, Manzari Aet al. Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues. J Steroid Biochem Mol Biol. 52:1995;541-546.
41. Reed MJ, Purohit A Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocr Rev. 18:1997;701-715.
42. Reed MJ, Topping L, Coldham NGet al. Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors. J Steroid Biochem Mol Biol. 44:1993;589-596.
43. Reed MJ, Rea D, Duncan LJ, Parker MG Regulation of estradiol 17β-hydroxy-steroid dehydrogenase expression and activity by retinoic acid in T47D breast cancer cells. Endocrinology. 135:1994;4-9.
44. Saez JM, de Peretti E, Morera AMet al. Familial male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect. Studies in vivo. J Clin Endocrinol Metab. 32:1971;604-610.
45. Sawetawan C, Milewich L, Word RAet al. Compartmentalization of type I 17β-hydroxysteroid oxidoreductase in the human ovary. Mol Cell Endocrinol. 99:1994;161-168.
46. Tilson-Mallett N, Santner SJ, Feil PD, Santen RJ Biological significance of aromatase activity in human breast tumors. J Clin Endocrinol Metab. 57:1983;1125-1128.
47. Urano R, Sakabe K, Seiki K, Ohkido M Female sex hormone stimulates cultured human keratinocyte proliferation and its RNA-synthetic and protein synthetic activities. J Dermatol Sci. 9:1995;176-184.
48. Wilson JD, Griffin JE, Russell DW Steroid 5α-reductase 2 deficiency. Endocr Rev. 14:1993;577-593.
49. Wu L, Einstein M, Geissler WMet al. Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity. J Biol Chem. 268:1993;12964-12969.
50. Zhang Y, Word RA, Fesmire S, Carr BR, Rainey WE Human ovarian expression of 17β-hydroxysteroid dehydrogenase types 1, 2, and 3. J Clin Endocrinol Metab. 81:1996;3594-3598.